Home Authors Posts by Alisa Kirkin

Alisa Kirkin

39 POSTS 0 COMMENTS
Treatment with lipid Nanoparticles, Genetic therapy, Fluorescent staining
Eye Disorders

Lipid Nanoparticle Technology May Advance Gene Therapy for Blindness

Illustration of CAR T-cell immunotherapy, similar to that developed by Autolus Therapeutics
CAR-T

New Biomarker Predicting Response to CAR-T Cell Therapy Discovered

Treating Cancer
News & Features

Researchers Develop Artificial DNA That Kills Cancer Cells

Glioblastoma brain cancer, CT scan
Biomarkers

UCSF Researchers Identify the Cellular Source of Recurrent Glioblastoma

Illustration showing tumor inside prostate gland and closeup view of prostate cancer cells to the left of the image.
Molecular Diagnostics/In vitro Diagnostics

Researchers Develop New Method for Prostate Cancer Screening

3d illustration of the human brain with visible blood vessels illustrating alzheimer’s disease
Neurological Disorders

Higher Vitamin D Levels Linked to Improved Cognitive Function in Dementia...

Pancreatic cancer, malignant tumor of pancreas with KRAS mutation
Drug Discovery

Study Shows Success of New Anti-KRAS Drug for Pancreatic Cancer

Colorectal cancer, intestinal carcinoma, colon cancer, bowel neoplasia, 3D illustration
Colorectal Cancer

Researchers Identify Cells Responsible for Colon Cancer Relapse

Hospitalized cancer patient undergoing chemotherapy.
Breast Cancer

Potential New Treatment Improving Chemotherapy Efficacy and Reducing Metastasis Discovered

Image illustrating man with cardiovascular disease
Cardiovascular Disease

New siRNA Therapy Significantly Reduces Cholesterol Levels in Patients with Cardiovascular...

1234Page 3 of 4

Trending

Lung Cell Atlas Created

Lung Cell Atlas Created

Penn Medicine Nabs $6M NIH Grant to Study Cardiac Cell Development

Penn Medicine Nabs $6M NIH Grant to Study Cardiac Cell Development

Melanoma Survival Improved by Memory Killer Cells

Melanoma Survival Improved by Memory Killer Cells

Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years

Real-World Data Reassure Advanced NSCLC Patients Stopping Immunotherapy at Two years

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine